[The Petri Dish] Patents for New Plant Varieties in Europe?
Generics vs. Patented Drugs
By Samini Thiruchelvam & P. Kandiah India’s incredible advancement in various fields of technology (including launching its own first ever Mars mission!) has attracted other nations to establish a trading relationship with India. This is further exemplified by President Obama’s recent visit to India in pursuant of a Free Trade Agreement (FTA) with the fast-developing […]
[The Petri Dish] Generics vs Patented Drugs
[The Petri Dish] Academic papers and patent specifications – A closer look
Owning Animal Clones…
By Samini Thiruchelvam & P. Kandiah Dolly was the very first cloned animal and it carried the hopes of cloning enthusiasts for improved drug production and possibly, revival of endangered species. The fathers of Dolly – Keith Henry Stockman Campbell and Ian Wilmut from the Roslin Institute of Edinburgh (“Roslin”) – created Dolly in 1996 […]
[The Petri Dish] Owning Animal Clones
[The Petri Dish] Gene Patenting – So what happens now?
[The Petri Dish] The Trans-Pacific Partnership: A Whiff of What can be Expected
[The Petri Dish] Stem Cell Research: Embryonic vs Non-Embryonic
The Bolar Provision: A Defense to Patent Infringement
By P. Kandiah & Kimberly Liam What happens when a patent for a particular drug expires or is about to expire? Patented drugs lose their patent exclusivity as they go off patent and pharmaceutical companies that own these patents start to worry as the generic pharmaceutical companies begin to sell their drugs in the market. […]